Product Information
VORICONAZOLE 200 MG TABLET is a generic product labeled by Sandoz Inc., priced at $1.8846 per EA under NDC 00781566831. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 12, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Sandoz Inc.NDC
00781566831
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VORICONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA200265FDA Approved
12/12/2011
TE Code
AB
On Market Since
12/12/2011
Pharmacological Classes
Price Statistics
The NADAC for VORICONAZOLE 200 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 93.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8846 per EA |
|---|---|
| All-time high | $27.5829 (Feb 12, 2014) |
| All-time low | $1.3268 (Sep 20, 2023) |
| 52-week high | $2.2348 |
| 52-week low | $1.7468 |
| Median price | $4.7461 |
| Average price | $7.6315 |
| Largest weekly change | -61.5% (Jun 23, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
voriconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VORICONAZOLE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VORICONAZOLE 200 MG TABLET, manufactured by Sandoz Inc., is $1.8846 per EA (NDC 00781566831), effective Sep 30, 2026.
How has the price of VORICONAZOLE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for VORICONAZOLE 200 MG TABLET has declined 93.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VORICONAZOLE 200 MG TABLET?
Since Nov 28, 2013, the NADAC for VORICONAZOLE 200 MG TABLET has ranged from a low of $1.3268 (Sep 20, 2023) to a high of $27.5829 (Feb 12, 2014), with a median of $4.7461 per EA.
Are there cheaper alternatives to VORICONAZOLE 200 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VORICONAZOLE 200 MG TABLET, is $1.5586 per EA — about 17% below VORICONAZOLE 200 MG TABLET.
Who manufactures VORICONAZOLE 200 MG TABLET?
VORICONAZOLE 200 MG TABLET (NDC 00781566831) is labeled by Sandoz Inc., and CMS classifies it as a generic product.